Allergan urges shareholders to reject Valeant Pharmaceuticals takeover offer
MONTREAL - Allergan Inc. urged its shareholders Monday to reject a hostile takeover offer by Valeant Pharmaceuticals International Inc. (TSX:VRX) in the latest step in the bitter fight between the companies.
Allergan called the offer grossly inadequate and said it created significant risks and uncertainties for Allergan shareholders.
Valeant, which had tried to negotiate a deal to acquire Allergan, took its offer directly to the company's shareholders last week.
The company has offered US$72 in cash plus 0.83 of a Valeant share for each share of the Botox maker.
The bid values Allergan at more than US$50 billion.
The recommendation is the latest step in the takeover fight which threatens to become a prolonged battle.
Bill Ackman's Pershing Square Capital Management, which is backing the Valeant offer, is also seeking to call a special meeting of Allergan's shareholders to remove six directors.
Pershing owns 9.7 per cent of Allergan.
Read more Business News
- Smith Creek fireWest Kelowna - 5:00 pm
- BC tankers assist US firePenticton / S. Okanagan - 5:41 pm
- Stolen truck smashes storeCentral Okanagan - 5:34 pm
- Man missing since DecemberCentral Okanagan - 5:44 pm
|QHR Technologies Inc||1.19||+0.04|
|Anavex Life Sciences||0.33||-0.018|
|Copper Mountain Mining||2.83||+0.14|
|Sunrise Resources Ltd||0.025||-0.005|
|Mission Ready Services||0.19||+0.01|
The mainstream media are finally waking up to something unusual in British Columbia – a labour shortage. If the experience of Alberta is a guide to our own future, the highly skilled labour will...
Photo: ContributedI have the pleasure of witnessing people delegate tasks quite often. Sometimes with tremendous success and sometimes with disastrous consequences. I have chaired a lot of committees...
Big Picture Euro debt woes re-emerge Europe’s debt woes jumped back into the headlines this week trumping other economic, geopolitical and corporate developments. Word that one of Portugal&rsquo...